Antiphospholipid syndrome associated with cytomegalovirus infection: Case report and review

Clinical Infectious Diseases

Volumn 24, Issue 2, 1997, Pages 197-200

  Labarca, Jaime A ^a,b   Rabaggliati, Ricardo M ^a   Radrigan, Francisco J ^a   Rojas, Paula P ^a   Perez, Carlos M ^a   Ferrés, Marcela V ^a   Acũa, Guillermo G ^a   Bertin, Pablo A ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY;

ADULT; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; CLINICAL FEATURE; CYTOMEGALOVIRUS INFECTION; HUMAN; IMMUNOPATHOGENESIS; MALE; MESENTERIC VEIN THROMBOSIS; PRIORITY JOURNAL;

EID: 0031044766     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/24.2.197     Document Type: Article

References (18)

1. Bick RL. Hypercoagulability and thrombosis. Med Clin North Am 1994; 78:635-65.
2. Bick RL, Baker WF Jr. The antiphospholipid and thrombosis syndromes. Med Clin North Am 1994;78:667-84.
3. Lockshin MD. Antiphospholipid antibody syndrome. Rheum Dis Clin North Am 1994;20:45-59.
4. Ho M. Epidemiology of cytomegalovirus infections. Rev Infect Dis 1990; 12(suppl 7):S701-10.
5. Sunwen C. Newer methods for diagnosis of cytomegalovirus infection. Rev Infect Dis 1990;12(suppl 7):S727-36.
6. Ho M. Cytomegalovirus. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's principles and practice of infectious diseases. 4th ed. Vol 2. New York: Churchill Livingstone, 1995:1351-64.
7. Hughes GRV, Harris NN, Gharavi AE. The anticardiolipin syndrome. J Rheumatol 1986; 13:486-9.
8. Roubey RAS. Update on the antiphospholipid antibody syndrome. Cliniguide to Rheumatology 1994;4:l-8.
9. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. Ann Intern Med 1990; 112:682-98.
10. Canoso RT, Sise HS. Chlorpromazine-induced lupus anticoagulant and associated immunologic abnormalities. Am J Hematol 1982; 13:121-9.
11. Manoussakis MN, Tzioufas AG, Silis MP, Fange PJ, Goudevenos J, Moutsopoulos HM. High prelevance of anti-cardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol 1987;69: 557-65.
12. Vaarala O, Palosuo T, Kleemola M, Aho K. Anticardiolipin response in acute infections. Clin Immunol Immunopathol 1986;41:8-15.
13. Snowden N, Wilson PB, Longson M, Pumphrey RS. Antiphospholipid antibodies and Mycoplasma pneumoniae infection. Post Grad Med J 1990;66:356-62.
14. Adebajo AO, Charles P, Maini RN, Hazleman BL. Autoantibodies in malaria, tuberculosis and hepatitis B in a West African population. Clin Exp Immunol 1993;92:73-6.
15. Macworth-Young CG, Harris EN, Steere AC, et al. Anticardiolipin antibodies in Lyme disease. Arthritis Rheum 1988;31:1052-6.
16. Soni PN, De Bruyn CC, Duursma J, Sharpe BL, Pudifin DJ. Are anticardiolipin antibodies responsible for some complications of severe Plasmodium falciparum malaria? S Afr Med J 1993; 83:660-2.
17. Colaco CB, Mackie IJ, Irving W, Machin SJ. Anticardiolipin antibodies in viral infection [letter]. Lancet 1989;333:622.
18. Misra R, Venables PJV, Watkins RP, Maini RN. Autoimmunity to cardiolipin in infectious mononucleosis [letter]. Lancet 1987;2:629.